focus -WSS

focus

author：explore 2025-09-28 21:57:17 - browse：9432

A stethoscope lays on banknotes next to a calculator, all on top of a insurance application form — coverage from STAT — Adobe

Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report.

But investors have found pockets of profits by backing companies involved in enrolling seniors in MA plans and keeping track of them once they’re there. They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.

Overall, private equity investors made only 4 investments in Medicare Advantage-related companies last year, compared with 12 in 2022, down from a peak of 19 in 2021, per the Private Equity Stakeholder Project, a group focused on holding private equity firms accountable for their impacts on people and the planet, according to its website.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Alabama hospital puts IVF treatments on hold

focus

WSS

Reanimated hearts work just as well for transplants, study finds

A new nitrogen execution bill also undermines medical licensing

Timeline: Key moments in fight for gay rights

Bispecific antibodies are next new thing in cancer immunotherapy

Xenotransplantation trials will require adjusting expectations, experts say

Reanimated hearts work just as well for transplants, study finds

hotspot

focus

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

He's a Nobel laureate. Critics say he was misleading on Covid

Tori Bowie and the unacceptable rates of Black maternal death

Altering the blood type of lungs raises potential for universal organs for transplants

Medical records are filled with copy

A new nitrogen execution bill also undermines medical licensing

Medical records are filled with copy

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

As demand for Covid shots wanes, Moderna seeks its next success

In utero gene editing: an explainer

leisure time

Can medical device makers keep up in the race to treat obesity?

Alabama frozen embryo ruling has major implications for IVF clinics

Obesity drugs seen as possible treatment for liver disease MASH

Mom launches Girl Scout troop for LGBTQ youth in Texas

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

focus

leisure time

hotspot

hotspot